Disease | sudden cardiac death |
Phenotype | |heart failure |
Sentences | 53 |
PubMedID- 24278681 | Nonetheless, provided patients are carefully selected, the use of implantable cardioverter defibrillators for the primary prevention of sudden cardiac death in heart failure patients with severe lvsd despite optimal medical therapy appears to be cost effective [84]. |
PubMedID- 21603593 | The madit ii (multicentric automatic defibrillator implantation ii) trial, whose participants had a nonrecent mi and lvef < 30%, found a significant survival benefit after icd implantation.113 similar results were showed scd-heft (sudden cardiac death in heart failure) trial which evaluated patients with nonischemic or ischemic lv systolic dysfunction (lvef < 35%).114 according to current guidelines, icd is indicated for secondary prevention in patients who survive an unprovoked episode of ventricular fibrillation or sustained ventricular tachycardia and for primary prevention in patients with lv dysfunction (lvef ≤ 35%). |
PubMedID- 23036686 | Background: the mechanism of sudden cardiac death in patients with heart failure (hf) is uncertain. |
Page: 1 2